Pembrolizumab plus gemcitabine and cisplatin improves survival in advanced biliary tract cancer
1. Median overall survival was greater in the pembrolizumab group compared to the control group (12.7 months vs. 10.9 months). ...
1. Median overall survival was greater in the pembrolizumab group compared to the control group (12.7 months vs. 10.9 months). ...
1. In this retrospective cohort study, adult patients with hepatitis C virus (HCV) infection treated with direct-acting antiviral (DAA) agents ...
1. Bepirovirsen resulted in a sustained hepatitis B surface antigen (HBsAg) and hepatitis B virus (HBV) DNA loss in approximately ...
1. Adenovirus was found to be associated with the emerging hepatitis of unknown cause in children in the United Kingdom ...
1. In patients with hepatitis C virus who recently injected drugs, 67% in the accessible care arm vs 23% in ...
1. A retrospective, cross-sectional study including all pregnancies in the United States between 2009 and 2019 found that the annual ...
2 Minute Medicine is pleased to announce that we are launching Wellness Check, a new series dedicated to exploring new ...
1. Adding methylprednisolone to standard treatment in hepatitis B virus-related acute-on-chronic liver failure was associated with an increase in 6-month ...
1. In patients with severe alcoholic hepatitis, treatment with prednisolone or pentoxifylline did not significantly reduce mortality at 28 days. ...
In this section, we highlight the key high-impact studies, updates, and analyses published in medicine during the past week. Long-Term ...
2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.